Cencora to acquire Retina Consultants of AmericaThe acquisition is intended to expand Cencora's position in specialty. Bora Pharmaceuticals acquires Pyros PharmaceuticalsPyros is a specialty pharmaceutical company developing treatments for rare diseases. Shields, Sutter Health expand collaboration for patient access to specialty pharmacy services This pharmacy collaboration aims to expand care to patients who receive specialty medications to help treat chronic, rare and complex conditions. Lupin taps Claus Jepsen as president, global specialty Jepsen joins Lupin from Takeda Pharmaceuticals, where he led the global strategy for rare diseases. URAC releases specialty pharmacy report Over the five-year period, URAC-accredited pharmacies responded to patient calls within 30 seconds 75% of the time, improving to 86% by 2023. Elite rolls out generic Tylenol with Codeine Acetaminophen and codeine phosphate tablets are indicated for the management of mild to moderate pain. Kroger closes sale of specialty pharmacy business Kroger finalized its specialty pharmacy business sale to Elevance Health. Hikma completes Xellia acquisition The acquisition includes a commercial portfolio and pipeline of differentiated products, a manufacturing facility in Cleveland, Ohio, sales and marketing capabilities and an R&D center in Zagreb, Croatia. Patrick Soon-Shiong joins Avenacy Soon-Shiong brings more than 25 years of pharmaceutical industry experience, including successful commercialization of injectable generic drugs. Upsher-Smith selects PANTHERx Rare to distribute Torpenz Torpenz Tablets are used for the treatment of Tuberous Sclerosis Complex. 1 2 3 4 5 Next Last
